Sino Biological, Inc., currently listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), is an international reagent supplier and premium technical contract service, provider. Since 2007, we have committed to providing high-quality, independently developed, and produced recombinant proteins, antibodies, and cDNA clones for basic, translational, and clinical research.